302 results
P
SA+ patients, SA- patients, healthy controls
I/C
blood biomarkers, immune, inflammatory, and neurotoxic profiles, meta-analysis, SA+ vs. healthy controls, SA+ vs. SA-, current vs. lifetime SA
O
increased immune activation, inflammation, neurotoxicity, lowered neuroprotection, risk of SA
P
individuals with pre-existing sleep apnea (SA), individuals without SA, 25,062 SA cases, 313,372 controls, 20,582 glaucoma cases, 119,318 controls
I/C
genetic data, two-sample Mendelian randomization (MR) analyses, genome-wide association study (GWAS), inverse variance weighted regression of genetic susceptibility for SA on risk of glaucoma, genetically predicted SA and glaucoma susceptibility
O
association between SA and glaucoma, risk of glaucoma
P
I/C
l, o, w, -, l, e, v, e, l, , a, r, s, e, n, i, c, , (, A, s, ), , c, o, n, c, e, n, t, r, a, t, i, o, n, , i, n, , d, r, i, n, k, i, n, g, , w, a, t, e, r, d, r, i, n, k, i, n, g, , w, a, t, e, r, , A, s, , c, o, n, c, e, n, t, r, a, t, i, o, n, s, , l, o, w, e, r, , t, h, a, n, , t, h, e, , W, H, O, , p, r, o, v, i, s, i, o, n, a, l, , g, u, i, d, e, l, i, n, e, , v, a, l, u, e, , (, 1, 0, , µ, g, /, L, )
O
p, o, o, l, e, d, , a, s, s, o, c, i, a, t, i, o, n, , b, e, t, w, e, e, n, , t, h, e, , r, e, l, a, t, i, v, e, , r, i, s, k, , o, f, , e, a, c, h, , c, a, r, d, i, o, v, a, s, c, u, l, a, r, , d, i, s, e, a, s, e, , (, C, V, D, ), , e, n, d, p, o, i, n, t, , a, n, d, , l, o, w, -, l, e, v, e, l, , A, s, , c, o, n, c, e, n, t, r, a, t, i, o, n, , i, n, , d, r, i, n, k, i, n, g, , w, a, t, e, r
P
1200 participants
I/C
Acupuncture alone, Acupuncture combined with vitamin B, Vitamin B
O
Clinical efficacy
P
pollen, UV-B radiation
I/C
UV-B radiation, pollen germination and tube growth
O
substantial reduction in both pollen germination and tube growth
P
NAFLD participants, controls
I/C
fetuin-A, fetuin-B, compared with controls
O
strength of the association between fetuin-A, fetuin-B, and NAFLD
P
HBV-infected subjects, uninfected subjects
I/C
ABO blood groups, non-B blood group
O
risk of HBV infection
P
COVID-19, case subjects, control subjects
I/C
ABO blood group, blood groups A, O, B, and AB
O
odds of having each blood group
P
nurses
I/C
health education and counselling, case management and health promotion, running specialist clinics, no intervention
O
increased hepatitis B screening and detection rates, increased odds of hepatitis B virus vaccination, improved immunity rate, enhanced patient adherence to antiviral treatment and monitoring of liver comorbidities
P
pre-menopausal women, post-menopausal women
I/C
B/L oophorectomy, no B/L oophorectomy
O
incidence of Parkinson's disease and parkinsonism